Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 55.11

-2.6%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Pseudo Biologist who wrote (383)	9/21/1999 3:01:00 PM
From: Biomaven	Read Replies (2) of 52153

Boy, does Lehman have egg-on-its-face on this one. Talking about "better visibility" of "future earnings" for ... QTRN That's part of the reason the market generally over-reacts to an earnings disappointment - the analysts are sufficiently pissed off to want to be as far away from the company as possible. Of course it takes a while for a company to "earn" its credibility back, and some never do. In this particular case, QTRN magnified its boo-boo by agreeing with the analyst estimates just a few weeks ago. However, if you believe in the long-term fundamentals and don't mind being patient, I think now is a pretty good time to buy. I picked up some at around $18 to add to my small (particularly small after the crash <g>) existing position. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next